How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

10,809 results for

Management of Severe Head Injury

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. Serum S100B Protein Assay in Mild Head Injury

Serum S100B Protein Assay in Mild Head Injury Serum S100B Protein Assay in Mild Head Injury - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Serum S100B Protein Assay in Mild Head Injury (TCLAS-100B (...) : Cohort Time Perspective: Prospective Official Title: Evaluation of the Serum S100B Protein Assay in the Management of Mild Head Injury Under Anticoagulation Estimated Study Start Date : March 1, 2018 Estimated Primary Completion Date : March 1, 2020 Estimated Study Completion Date : July 1, 2020 Resource links provided by the National Library of Medicine related topics: Groups and Cohorts Go to Intervention Details: Diagnostic Test: serum S100B protein assay measurement serum S100B protein assay

2017 Clinical Trials

122. PATTERN OF REFERRALS OF HEAD INJURY TO THE UNIVERSITY COLLEGE HOSPITAL, IBADAN Full Text available with Trip Pro

PATTERN OF REFERRALS OF HEAD INJURY TO THE UNIVERSITY COLLEGE HOSPITAL, IBADAN Although there are now many neurosurgical units in Nigeria, cases of head injury (HI) continue to present in the University College Hospital, UCH, Ibadan, from hospitals all over the country.This report aims to highlight the contemporary patterns of referrals of cases of head injury for neurosurgery in Ibadan.The study emanated from an analysis of registry of cases of head injury managed in our practice covering a 7 (...) in other health facilities in four out of Nigeria's six geopolitical zones including other teaching hospitals with practicing neurosurgeons. The reasons for these inter-hospital, inter-state referrals included absence of neurosurgical expertise (67%) or lack of other logistics like neuroimaging, bed space and intensive care unit services. Head Injury was caused by road accidents in more than 85% of the cases. The patients referred inter-state had more severe injuries, more delayed attainment

2017 Annals of Ibadan postgraduate medicine

123. Antioxidants in experimental ischemia-reperfusion injury of the testis: Where are we heading towards? Full Text available with Trip Pro

Antioxidants in experimental ischemia-reperfusion injury of the testis: Where are we heading towards? Testicular torsion (TT) is a medical emergency that primary affects newborns and young adolescents. It causes testicular injury due to the torsion of the spermatic cord and its components, initially in the venous blood flow and finally in the arterial blood flow. Prompt diagnosis and early surgical management are necessary in managing this urgent situation. The process of the pathophysiological (...) events in ischemia-reperfusion is multifactorial and deals with the perception of the oxidative stress responsible for the consequences of ischemia/reperfusion (I/R) stress following TT. Duration and severity of torsion also play a significant role in the oxidative stress. A detrimental result of the defense system of the testes takes place resulting finally in testicular atrophy and impaired function. Antioxidant factors have been experimentally studied in an effort to front this state. They have

2017 World journal of methodology

124. Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department With Acute Headache

be considered, 102 the literature as a whole is predominantly represented by studies focused on diagnosis of SAH. As a result, this 103 clinical policy addresses circumstances in which intracranial saccular berry aneurysms or arteriovenous 104 malformations are the suspected rule-out diagnosis. However, the clinician should keep in mind that there are other 105 unusual causes of acute severe headache that may require urgent diagnosis and management. For example, among 106 thunderclap headaches presenting (...) rule in or rule out significant pathology associated with acute severe headaches, thereby avoiding acute 330 ED brain imaging, is warranted. The availability of reliable and immediately available laboratory testing would 331 have dramatic effect on the evaluation of acute headache complaints in the ED. 332 333 2. In the adult ED patient treated for acute primary headache, are nonopioids preferred to opioid 334 medications? 335 336 Patient Management Recommendations 337 Level A recommendations

2019 American College of Emergency Physicians

125. Mild fetal ventriculomegaly: diagnosis, evaluation, and management

.Papageorghiou AT, Thilaganathan B, Bilardo CM, et al. ISUOG interim guidance on ultrasound for Zika virus infection in pregnancy: information for healthcare professionals. Ultrasound Obstet Gynecol 2016;47:530-2. 29.Society for Maternal-Fetal Medicine (SMFM), Hughes BL, Gyam?- Bannerman C. Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J ObstetGynecol 2016;214:B5-11. 30.American College of Obstetricians and Gynecologists. Cytomegalo- virus, parvovirus B19, varicella zoster (...) Mild fetal ventriculomegaly: diagnosis, evaluation, and management Mild fetal ventriculomegaly: diagnosis, evaluation, and management Society for Maternal-Fetal Medicine (SMFM); Nathan S. Fox, MD; Ana Monteagudo, MD; Jeffrey A. Kuller, MD; Sabrina Craigo, MD; and Mary E. Norton, MD Thepracticeofmedicinecontinuestoevolveandindividualcircumstanceswillvary.Thisopinionre?ectsinformation available at the time of acceptance for publication and is neither designed nor intended to establish

2019 Society for Maternal-Fetal Medicine

126. Assessment and Management of Patients at Risk for Suicide

be considered, if appropriate. This CPG is designed to assist providers in managing or co-managing patients at risk for suicide as well as any co-occurring conditions (e.g., major depressive disorder [MDD], generalized anxiety disorder, SUD, posttraumatic stress disorder [PTSD], traumatic brain injury [TBI]). VA/DoD CPGs exist for MDD 2 , mild TBI 3 , PTSD 4 , SUD 5 , and opioid therapy for chronic pain 6 . Moreover, the patient population of interest for this CPG is patients at risk for suicide who (...) are eligible for care in the VA and DoD healthcare delivery systems 2 See the VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder. Available at: https://www.healthquality.va.gov/guidelines/MH/mdd/ 3 See the VA/DoD Clinical Practice Guideline for the Management of Concussion-mild Traumatic Brain Injury. Available at: https://www.healthquality.va.gov/guidelines/Rehab/mtbi/ 4 See the VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute

2019 VA/DoD Clinical Practice Guidelines

127. Management of Stroke Rehabilitation

The 2019 edition of the VA/DoD Stroke Rehabilitation CPG is the third update to the original CPG. It provides practice recommendations for rehabilitation of stroke as well as guidance for specialty referral. A particular strength of this CPG is the interdisciplinary stakeholder involvement from its inception, ensuring representation from the broad spectrum of clinicians engaged in the treatment and management of stroke rehabilitation with and without co-occurring conditions. The framework (...) Management of Stroke Rehabilitation VA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF STROKE REHABILITATION Department of Veterans Affairs Department of Defense QUALIFYING STATEMENTS The Department of Veterans Affairs and the Department of Defense guidelines are based upon the best information available at the time of publication. They are designed to provide information and assist decision making. They are not intended to define a standard of care and should not be construed as one

2019 VA/DoD Clinical Practice Guidelines

128. Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations

current recommendations regarding ICI therapy, though the evidence and strength of recommendations for the management of CV toxicity as part of these guidelines is preliminary and relatively scant in practical detail. 200e202 The ongoing reporting and representation of the diagnosis and management of ICI-related CV toxicity is rapidly changing. At the present time, there are several clinical reports that inform the current recommendations. 203e211 As such, these recommendations are formulated based (...) Management of Cardiac Disease in Cancer Patients Throughout Oncological Treatment: ESMO Consensus Recommendations SPECIAL ARTICLE Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations G. Curigliano 1,2y , D. Lenihan 3y , M. Fradley 4 , S. Ganatra 5 , A. Barac 6 , A. Blaes 7 , J. Herrmann 8 , C. Porter 9 , A. R. Lyon 10 , P. Lancellotti 11 , A.Patel 12 , J.DeCara 13 , J. Mitchell 14 , E. Harrison 15 , J.Moslehi 16 , R.Witteles 17 , M

2020 European Society for Medical Oncology

129. Management of Rheumatod Arthritis

severe disease. ACPA should be considered in clinically suspected RA where RF is negative. Both RF and ACPA are not recommended for disease monitoring. Phase of management Investigations • Inflammatory markers o Erythrocyte sedimentation rate (ESR) and/or o C-reactive protein (CRP) • Rheumatoid factor (RF) and/or • Anti-citrullinated peptide antibody (ACPA)* • Full blood count (FBC) • Renal profile (RP) • Fasting blood sugar • Fasting lipid profile • Liver function test (LFT) • Viral hepatitis (...) should provide the following information: ? Symptoms and signs: duration, joint distribution, severity and impact on activity of daily living ? Extra-articular involvement ? Co-morbidities that may require further medical assessment ? Current medications ? Relevant investigation results Recommendation 3 • All patients suspected of having rheumatoid arthritis (RA) should be referred to the rheumatologist. • All RA patients should be primarily managed by rheumatologists. ? Co-management plan

2019 Ministry of Health, Malaysia

130. Management of Acute ST Segment Elevation Myocardial Infarction (STEMI) – (4th Edition)

Ampuan Rahimah, Klang, Selangor Dr Gunavathy Muthusamy Consultant Physician/Endocrinologist, Head of General Medicine, Hospital Shah Alam Dr Lee Kun Yun Public Health Specialist, Institute for Health Management, Ministry of Health Dr Narul Aida Salleh Family Medicine Specialist, Klinik Kesihatan Kuala Lumpur Dr Ong Mei Lin Consultant Cardiologist, Gleneagles Penang Dr Saari Mohamad Yatim Consultant Rehabilitation Physician, Hospital Serdang Dr Sabariah Faizah Jamaluddin Consultant Emergency Physician (...) infarction (MI)”; “STEMI”; ST Elevation Myocardial Infarction;” “definition of MI”; “Myocardial injury”, “ECG criteria of STEMI”, “Pre-hospital Management of STEMI”; “STEMI Networks”; “Pre-hospital thrombolysis”; “Fibrinolysis”; “Primary PCI”; “Reperfusion strategies in STEMI”; “Pharmaco-invasive strategy”; “Pharmacotherapy in STEMI”; “Oxygen therapy in MI”; “Complications post STEMI”, “cardiogenic shock”; “Heart Failure post STEMI”; “Risk stratification scores in STEMI”; “Cardiac rehabilitation

2019 Ministry of Health, Malaysia

131. Management of Heart Failure (4th Edition)

Practice Guidelines, Ministry of Health Malaysia and key health personnel in the major hospitals of the Ministry of Health and the private sector for review and feedback.8 Clinical Questions Addressed: There were several topics and subtopics that were formulated addressing the diagnosis and management of HF. For diagnosis: In a person presenting with shortness of breath: ? What features in the history and clinical examination would make one suspect this patient is having a HF? ? What diagnostic tests (...) Management of Heart Failure (4th Edition) MOH/P/PAK/421.19(GU)-ePUBLISHED BY: National Heart Association of Malaysia D-13A-06, Menara SUEZCAP 1, KL Gateway No.2 Jalan Kerinchi, Gerbang Kerinchi Lestari 59200 Kuala Lumpur eISBN 978-967-11794-4-4 COPYRIGHT The owners of this publication are the National Heart Association of Malaysia (NHAM) and the Academy of Medicine Malaysia. The content in this document may be produced in any number of copies and in any format or medium provided

2019 Ministry of Health, Malaysia

132. Review of information management practices in the HSE Computerised Infectious Disease Reporting (CIDR) system

CIDR is meeting its objectives as Ireland’s national surveillance system for infectious diseases. CIDR was developed to provide near real-time regional and national surveillance of infectious diseases, to facilitate public health action and to allow Ireland to meet its international reporting obligations. Arising from this review HIQA has concluded that while CIDR fulfils many of its intended functions and HPSC demonstrates good practice in several aspects of information management, the system has (...) that the committee was established as a project management group to steer the implementation of CIDR and has not evolved sufficiently to oversee the strategic direction and future development of CIDR. When CIDR was established, the Director of HPSC, as head of the managing organisation, held overall responsibility for information management in relation to CIDR. However, this role was vacant from May 2016 to June 2019, and was back-filled by the Assistant National Director for Public Health, Health Protection

2019 HIQA Health Information

133. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy Full Text available with Trip Pro

the clinician with guidance on evaluation and management of ACM and includes clinically relevant information on genetics and disease mechanisms. PICO questions were utilized to evaluate contemporary evidence and provide clinical guidance related to exercise in arrhythmogenic right ventricular cardiomyopathy. Recommendations were developed and approved by an expert writing group, after a systematic literature search with evidence tables, and discussion of their own clinical experience, to present the current (...) 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy - Heart Rhythm Email/Username: Password: Remember me Search both HRS Journals Search Terms Search within Search Access provided by Volume 16, Issue 11, Pages e301–e372 2019 HRS expert consensus statement on evaluation, risk stratification, and management

2019 International Society for Heart and Lung Transplantation

134. Pharmacological Management of Osteoporosis in Postmenopausal Women Full Text available with Trip Pro

Pharmacological Management of Osteoporosis in Postmenopausal Women We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite (...) Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation May 2019 Article Contents Article Navigation Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline Richard Eastell University of Sheffield, Sheffield, United Kingdom Search for other works by this author on: Clifford J Rosen Maine Medical Center Research Institute, Scarborough, Maine Correspondence: Clifford J. Rosen, MD

2019 The Endocrine Society

135. Management of Infertility

Management of Infertility Management of Infertility Comparative Effectiveness Review Number 217 RComparative Effectiveness Review Number 217 Management of Infertility Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00004-I Prepared by: Duke Evidence-based Practice Center Durham, NC Investigators: Evan R. Myers, M.D., M.P.H. Jennifer L. Eaton, M.D., M.S.C.I. Kara (...) . Suggested citation: Myers ER, Eaton JL, McElligott KA, Moorman PG, Chatterjee R, Zakama AK, Goldstein K, Strauss J, Coeytaux RR, Goode A, Borre E, Swamy GK, McBroom AJ, Lallinger K, Schmidt R, Davis JK, Hasselblad V, Sanders GD. Management of Infertility. Comparative Effectiveness Review No. 217. (Prepared by the Duke Evidence-based Practice Center under Contract No. 290-2015-00004-I.) AHRQ Publication No. 19-EHC014-EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2019. Posted final

2019 Effective Health Care Program (AHRQ)

136. Benign Prostatic Hyperplasia: Surgical Management of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms

and the severity of lower urinary tract symptoms (LUTS) in the aging male can be progressive and is an important diagnosis in the healthcare of patients and the welfare of society. In the management of bothersome LUTS, it is important that healthcare providers recognize the complex dynamics of the bladder, bladder neck, prostate, and urethra, in addition to the fact that symptoms may result from interactions of these organs as well as with the central nervous system or other systemic diseases (e.g., metabolic (...) who are at higher risk of bleeding, such as those on anti-coagulation drugs. (Expert Opinion) Introduction Purpose Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the aging male can be progressive and is an important diagnosis in the healthcare of patients and the welfare of society. In the management

2019 American Urological Association

137. Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer

the rationale for and evidence supporting treatment deintensification in the management of p16+ oropharyngeal cancer (OPC). STATEMENT OF THE CLINICAL ISSUE Section: The human papillomavirus (HPV) has been identified as the etiologic agent in the majority of patients with squamous cell carcinoma of the oropharynx (tonsil and base of tongue) in North America and northern Europe. Unlike tobacco-induced squamous cell cancer, which represents most cancers at other head and neck subsites, HPV-mediated OPC (...) Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.19.00441 Journal of Clinical Oncology - published online before print April 25, 2019 PMID: Role of Treatment

2019 American Society of Clinical Oncology Guidelines

138. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures

and advanced airway skills, such as, but not limited to, a physician anesthesiologist, an oral surgeon, a dentist anesthesiologist, or other medical specialists with the requisite licensure, training, and competencies; a certified registered nurse anesthetist or certified anesthesiology assistant; or a nurse with advanced emergency management skills, such as several years of experience in the emergency department, pediatric recovery room, or intensive care setting (ie, nurses who are experienced (...) Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures | From the American Academy of Pediatrics | Pediatrics '); document.write(''); } function OAS_AD(pos) { if (OAS_version >= 11 && typeof(OAS_RICH)!='undefined') { OAS_RICH(pos); } else { OAS_NORMAL(pos); } } //--> Search

2019 American Academy of Pediatrics

139. The management of obstructive azoospermia: a committee opinion

The management of obstructive azoospermia: a committee opinion The management of obstructive azoospermia: a committee opinion PracticeCommitteeoftheAmericanSocietyforReproductiveMedicineincollaborationwiththeSocietyfor Male Reproduction and Urology American Society for Reproductive Medicine, Birmingham, Alabama Infertilityduetoobstructiveazoospermiamaybetreatedeffectivelybysurgicalreconstructionorbyretrievalofspermfromtheepidid- ymisortestis (...) to a complete absence of sperm in the ejaculate, and accounts for approximately 40% of all cases of azoospermia (1). Obstruction may be congenitaloracquiredandmayinclude oneormoresegmentsofthemalerepro- ductive tract: epididymis, vas deferens, and ejaculatory ducts. Congenital causes of obstructive azoospermia include congenital bilateral absence of thevasdeferens(CBAVD)andidiopathic epididymal obstruction. Acquired causes of obstructive azoospermia include vasectomy, infection, trauma, or iatrogenic injury

2019 Society for Assisted Reproductive Technology

140. Sepsis Management

reported reductions in mortality from severe sepsis/septic shock in the order of 20-30%. This National Clinical Guideline is intended to be relevant to all healthcare staff involved in the care of patients who have sepsis. The Guideline Development Group consisted of a subgroup of the National Sepsis Steering Committee with expertise in guideline and early warning score implementation, sepsis management and emergency care. The Guideline Development Group has provided a number of recommendations (...) to assist healthcare staff in the identification and management of patients with sepsis. A summary version of the National Clinical Guideline outlining the key recommendations, is available at: www.health.gov.ie/patient-safety/ncec The recommendations align with the aims of the national sepsis work stream. Key recommendations are linked with other recommendations, practical guidance, roles, responsibilities and processes. The recommendations are linked to the best available evidence and/or expert

2019 National Clinical Guidelines (Ireland)

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>